Patents by Inventor Gerald S. JONES

Gerald S. JONES has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230372279
    Abstract: The present invention is directed to a pharmaceutical composition comprising a pharmaceutically acceptable carrier and a methanesulfonylalkylnitrile compound, or a pharmaceutically acceptable salt or solvate thereof. The present invention is also directed to a method for treating inflammation, inflammatory-related disorders, or pain, by administering a methanesulfonylalkylnitrile compound or a pharmaceutically acceptable salt or solvate thereof to a subject in need thereof.
    Type: Application
    Filed: March 17, 2023
    Publication date: November 23, 2023
    Inventors: Joseph St. Laurent, Gerald S. Jones, David M. Bresse
  • Publication number: 20230285359
    Abstract: A composition of psilocin that is stable including at least one agent or chemical modification that provides enhanced stability. A method making stable psilocin, by providing a formulation of psilocin including at least one agent or chemical modification that provides enhanced stability. A method of treatment of a disease or condition, by administering a composition of psilocin that is stable to an individual and treating the disease or condition.
    Type: Application
    Filed: May 31, 2023
    Publication date: September 14, 2023
    Applicant: Mind Medicine, Inc.
    Inventors: Robert BARROW, Peter MACK, Stephen SCHNEIDER, Jon SCHROEDER, Gerald S. JONES
  • Publication number: 20230054325
    Abstract: Described herein are methods for making folic acid derivatives, intermediates, pharmaceutical compositions and uses thereof.
    Type: Application
    Filed: July 26, 2022
    Publication date: February 23, 2023
    Inventors: Gerald S. Jones, JR., Joseph P. St. Laurent, Scott A. Goodrich
  • Publication number: 20220378044
    Abstract: Described herein are compounds that act as antimicrobial agents, compositions comprising these compounds, and methods of their use in to treating infections caused by Helicobacter pylori (H. pylori) or killing or inhibiting the growth of H. pylori.
    Type: Application
    Filed: March 16, 2022
    Publication date: December 1, 2022
    Inventors: Gerald S. Jones, JR., Joseph P. St. Laurent, Scott A. Goodrich
  • Publication number: 20220370413
    Abstract: A composition of psilocin that is stable including at least one agent or chemical modification that provides enhanced stability. A method making stable psilocin, by providing a formulation of psilocin including at least one agent or chemical modification that provides enhanced stability. A method of treatment of a disease or condition, by administering a composition of psilocin that is stable to an individual and treating the disease or condition.
    Type: Application
    Filed: August 8, 2022
    Publication date: November 24, 2022
    Applicant: Mind Medicine, Inc.
    Inventors: Robert BARROW, Peter MACK, Stephen SCHNEIDER, Jon SCHROEDER, Gerald S. JONES, JR.
  • Patent number: 11427589
    Abstract: Described herein are methods for making folic acid derivatives, intermediates, pharmaceutical compositions and uses thereof.
    Type: Grant
    Filed: February 4, 2020
    Date of Patent: August 30, 2022
    Assignee: JSB PHARMA DEVELOPMENT, LLC
    Inventors: Gerald S. Jones, Jr., Joseph P. St. Laurent, Scott A. Goodrich
  • Publication number: 20210059971
    Abstract: The present invention is directed to a pharmaceutical composition comprising a pharmaceutically acceptable carrier and a methanesulfonylalkylnitrile compound, or a pharmaceutically acceptable salt or solvate thereof. The present invention is also directed to a method for treating inflammation, inflammatory-related disorders, or pain, by administering a methanesulfonylalkylnitrile compound or a pharmaceutically acceptable salt or solvate thereof to a subject in need thereof.
    Type: Application
    Filed: August 24, 2020
    Publication date: March 4, 2021
    Inventors: Joseph ST. LAURENT, Gerald S. JONES, David M. BRESSE
  • Publication number: 20210052545
    Abstract: The present invention relates to a composition such as an anhydrous gel, comprising a cannabinoid and a silicone-based excipient, methods of administering the composition to a subject, and methods of treatment using said compositions.
    Type: Application
    Filed: October 30, 2020
    Publication date: February 25, 2021
    Inventors: Gerald S. Jones, JR., Joseph P. St. Laurent, Scott A. Goodrich
  • Publication number: 20210045993
    Abstract: The present invention relates to a composition such as an anhydrous gel, and its use for example as a cosmetic base, comprising a silicone-based excipient and one or more carrier oils, and methods of administering the composition to a subject.
    Type: Application
    Filed: October 30, 2020
    Publication date: February 18, 2021
    Inventors: Gerald S. Jones, Jr., Joseph P. St. Laurent, Scott A. Goodrich
  • Publication number: 20210002281
    Abstract: Described herein are methods for making folic acid derivatives, intermediates, pharmaceutical compositions and uses thereof.
    Type: Application
    Filed: February 4, 2020
    Publication date: January 7, 2021
    Inventors: Gerald S. Jones, JR., Joseph P. St. Laurent, Scott A. Goodrich
  • Patent number: 10751316
    Abstract: The present invention is directed to a pharmaceutical composition comprising a pharmaceutically acceptable carrier and a methanesulfonylalkylnitrile compound, or a pharmaceutically acceptable salt or solvate thereof. The present invention is also directed to a method for treating inflammation, inflammatory-related disorders, or pain, by administering a methanesulfonylalkylnitrile compound or a pharmaceutically acceptable salt or solvate thereof to a subject in need thereof.
    Type: Grant
    Filed: December 11, 2017
    Date of Patent: August 25, 2020
    Assignee: Olatec Therapeutics LLC
    Inventors: Joseph St. Laurent, Gerald S. Jones, David M. Bresse
  • Patent number: 10590138
    Abstract: Described herein are methods for making folic acid derivatives, intermediates, pharmaceutical compositions and uses thereof.
    Type: Grant
    Filed: February 28, 2019
    Date of Patent: March 17, 2020
    Assignee: Chemic Laboratories, Inc.
    Inventors: Gerald S. Jones, Jr., Joseph P. St. Laurent, Scott A. Goodrich
  • Publication number: 20190328884
    Abstract: The present invention relates to a composition such as an anhydrous gel, comprising a silicone-based excipient, methods of administering the composition to a subject, and methods of treatment using said compositions.
    Type: Application
    Filed: June 11, 2018
    Publication date: October 31, 2019
    Inventors: Gerald S. Jones, JR., Joseph P. St. Laurent, Scott A. Goodrich
  • Publication number: 20190315749
    Abstract: Described herein are methods for making folic acid derivatives, intermediates, pharmaceutical compositions and uses thereof.
    Type: Application
    Filed: February 28, 2019
    Publication date: October 17, 2019
    Inventors: Gerald S. Jones, Jr., Joseph P. St. Laurent, Scott A. Goodrich
  • Patent number: 10441555
    Abstract: The present invention is directed to a pharmaceutical composition comprising a pharmaceutically acceptable carrier and ?-(methylsulfonyl)alkylamine or ?-(methylsulfonyl)alkylamide. The present invention is also directed to a method for treating inflammation, inflammatory-related disorders, or pain, by administering ?-(methylsulfonyl)alkylamine or ?-(methyl sulfonyl)alkylamide, or a pharmaceutically acceptable salt or solvate thereof to a subject in need thereof.
    Type: Grant
    Filed: September 9, 2016
    Date of Patent: October 15, 2019
    Assignee: Olatec Therapeutics LLC
    Inventors: Joseph P. St. Laurent, Gerald S. Jones, David M. Bresse
  • Patent number: 10273203
    Abstract: The present invention relates to purified compounds of 3-methanesulfonylpropionitrile, in which at least one of the hydrogen, oxygen, sulfur, and nitrogen atoms is substituted with a respective isotope that includes, but not limited to 2H (deuterium), 3H (tritium), 13C, 14C, 15N, 17O, 18O, and 35S. The purified compound has at least 90% purity. Preferred compounds are deuterated 3-methanesulfonylpropionitriles.
    Type: Grant
    Filed: April 4, 2018
    Date of Patent: April 30, 2019
    Assignee: Olatec Therapeutics LLC
    Inventors: Gerald S. Jones, Scott A. Goodrich, Joseph P. St. Laurent
  • Patent number: 10259813
    Abstract: Described herein are methods for making folic acid derivatives, intermediates, pharmaceutical compositions and uses thereof.
    Type: Grant
    Filed: March 5, 2018
    Date of Patent: April 16, 2019
    Assignee: Chemic Laboratories, Inc.
    Inventors: Gerald S. Jones, Jr., Joseph P. St. Laurent, Scott A. Goodrich
  • Publication number: 20190048011
    Abstract: Described herein are methods for making folic acid derivatives, intermediates, pharmaceutical compositions and uses thereof.
    Type: Application
    Filed: March 5, 2018
    Publication date: February 14, 2019
    Inventors: Gerald S. Jones, JR., Joseph P. St. Laurent, Scott A. Goodrich
  • Patent number: 10172822
    Abstract: The present invention relates to a pharmaceutical composition comprising a pharmaceutically acceptable carrier and 3-benzylsulfonylpropionitrile, or its pharmaceutically acceptable salts. The present invention also relates to methods of using the compound for treating inflammation or inflammatory-related disorders and pain.
    Type: Grant
    Filed: June 13, 2018
    Date of Patent: January 8, 2019
    Assignee: Olatec Therapeutics LLC
    Inventors: Joseph P. St. Laurent, Gerald S. Jones, David M. Bresse, Scott A. Goodrich
  • Publication number: 20180353459
    Abstract: The present invention is directed to a pharmaceutical composition comprising a pharmaceutically acceptable carrier and a methanesulfonylalkylnitrile compound, or a pharmaceutically acceptable salt or solvate thereof. The present invention is also directed to a method for treating inflammation, inflammatory-related disorders, or pain, by administering a methanesulfonylalkylnitrile compound or a pharmaceutically acceptable salt or solvate thereof to a subject in need thereof.
    Type: Application
    Filed: December 11, 2017
    Publication date: December 13, 2018
    Inventors: Joseph ST. LAURENT, Gerald S. Jones, David M. Bresse